Axelsson, K. F.
Woessner, M. N.
Litsne, H.
Wheeler, M.
Flehr, A.
King, A. J.
Kalén, M.
Vandenput, L.
Lorentzon, M.
Funding for this research was provided by:
Vetenskapsrådet
Sahlgrenska Universitetssjukhuset
Västra Götalandsregionen
University of Gothenburg
Article History
Received: 30 September 2021
Accepted: 18 January 2022
First Online: 27 January 2022
Declarations
:
: Dr Axelsson has received lecture fees from Lilly, Meda/Mylan and Amgen. Prof Lorentzon has received lecture fees from Astellas, Amgen, Lilly, UCB Pharma, Radius Health, Meda/Mylan, GE-Lunar and Santax Medico/Hologic. Mr Litsne and Drs Woessner, Wheeler, Flehr, King, Kalén, and Vandenput have no conflicts of interest.